G20.A2
Parkinson's disease without dyskinesia, with fluctuations
Clinical Classification Guidelines
Inclusion Terms
- Parkinson's disease without dyskinesia, with OFF episodes
Medical Intelligence & Overview
Parkinson's disease is a progressive neurological disorder that primarily affects movement. The specific type identified by ICD-10 code G20.A2 refers to Parkinson's disease without dyskinesia, characterized by episodes of 'OFF' states — times when medication effects diminish, and symptoms worsen. This condition involves a complex interplay of symptoms rooted in the degeneration of nerve cells in the brain that produce dopamine, a vital chemical for regulation of movement and mood.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Family history of Parkinson's disease may increase risk. Environmental factors: Exposure to certain toxins or pesticides might contribute. Age: Incidence increases with advancing age, especially after 60. Biological factors: Loss of dopamine-producing cells in the substantia nigra region of the brain. Other risk factors: Head injuries and certain chemical exposures may also play a role.
Key Symptoms: Tremors: Often starting in a limb, particularly at rest. Bradykinesia: Slowness of movement affecting daily activities. Rigidity: Stiffness felt in limbs and body. Postural instability: Impaired balance leading to increased fall risk. Fluctuating symptoms: Periods of 'ON' (better movement) and 'OFF' (worse symptoms), especially during medication cycles. Speech changes: Softer, quieter, or rushed speech. Writing difficulties: Handwriting may become smaller and more difficult. Reduced facial expression: Known as 'masked face,' with less emotional display.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is primarily clinical, based on medical history and neurological examination. Doctors assess the nature of movement symptoms and their progression. They also rule out other conditions with similar symptoms through various tests. Since there is no definitive test for Parkinson's disease, diagnosis often involves observing characteristic signs and response to medication. Imaging tests like DAT scans may support diagnosis, especially in uncertain cases.
Treatment Protocols: Medications: Levodopa combined with carbidopa remains the mainstay, helping replenish dopamine levels. Other drugs include dopamine agonists, MAO-B inhibitors, and COMT inhibitors. Managing fluctuations: Adjusting medication timing and dosing can help reduce 'OFF' episodes. Sometimes, advanced therapies like infusion treatments are considered. Physical therapy: Custom exercises can improve mobility, balance, and flexibility. Speech therapy: To address speech and swallowing difficulties. Occupational therapy: Support for daily activities and adaptive strategies. Surgical options: Deep Brain Stimulation (DBS) may be considered in advanced cases with significant fluctuations and motor symptoms.
Clinical Advice & FAQs
Billing Guidance
Is G20.A2 a billable ICD-10 code?
Yes, G20.A2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G20.A2?
Clinical documentation must specify the nature of Parkinson's disease without dyskinesia, with fluctuations and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
